ARCHIVES

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

Firm To Collaborate With R. W. Johnson On Vaccines.

December 1, 2000

Guest Editorial “Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot

September 26, 2014

NCI To Fund 3,232, Research Project Grants In Fiscal 1993

January 15, 1993

Scientific Opportunity Should Guide Fund Allocation, House Says

August 4, 1995

Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees

November 5, 1999